Your browser doesn't support javascript.
loading
Assembly of polymer micelles through the sol-gel transition for effective cancer therapy.
Khaliq, Nisar Ul; Oh, Keun Sang; Sandra, Febrina Carolina; Joo, Yeonhee; Lee, Juhyung; Byun, Youngro; Kim, In-San; Kwon, Ick Chan; Seo, Jae Hong; Kim, Sang Yoon; Yuk, Soon Hong.
Afiliación
  • Khaliq NU; College of Pharmacy, Korea University, 2511 Sejongro, Sejong 30019, Republic of Korea.
  • Oh KS; College of Pharmacy, Korea University, 2511 Sejongro, Sejong 30019, Republic of Korea.
  • Sandra FC; College of Pharmacy, Korea University, 2511 Sejongro, Sejong 30019, Republic of Korea.
  • Joo Y; College of Pharmacy, Korea University, 2511 Sejongro, Sejong 30019, Republic of Korea.
  • Lee J; College of Pharmacy, Korea University, 2511 Sejongro, Sejong 30019, Republic of Korea.
  • Byun Y; Department of Molecular Medicine and Biopharmaceutical Sciences, Graduate School of Convergent Science and Technology, Seoul National University, Seoul 151-742, Republic of Korea.
  • Kim IS; Center for Theragnosis, Korea Institute of Science and Technology, 39-1 Hawolgok-dong, Sungbuk-gu, Seoul 136-791, Republic of Korea; KU-KIST School, Korea University, Seoul 02841, Republic of Korea.
  • Kwon IC; Center for Theragnosis, Korea Institute of Science and Technology, 39-1 Hawolgok-dong, Sungbuk-gu, Seoul 136-791, Republic of Korea; KU-KIST School, Korea University, Seoul 02841, Republic of Korea.
  • Seo JH; Biomedical Research Center, Korea University Guro Hospital, Guro-gu, Seoul 08308, Republic of Korea.
  • Kim SY; Department of Otolaryngology, Asan Medical Center, University of Ulsan, College of Medicine, 388-1 Pungnap-dong, Songpa-gu, Seoul 138-736, Republic of Korea.
  • Yuk SH; College of Pharmacy, Korea University, 2511 Sejongro, Sejong 30019, Republic of Korea; Biomedical Research Center, Korea University Guro Hospital, Guro-gu, Seoul 08308, Republic of Korea. Electronic address: shyuk@korea.ac.kr.
J Control Release ; 255: 258-269, 2017 06 10.
Article en En | MEDLINE | ID: mdl-28456679
ABSTRACT
Photo-induced apoptosis-targeted chemotherapy (PIATC) was designed and characterized to propose a new protocol for improved chemotherapy. Intratumoral injection was selected as the mode of administration of the anticancer drug, doxorubicin (DOX). To extend the retention time of DOX at the tumor parenchyma, in-situ gel formation was induced through the sol-gel transition of the Pluronic NPs containing a prodrug of DOX or a photosensitizer. The prodrug (DEVD-S-DOX) was designed to be inactive with a peptide moiety (Aspartic acid-Glutamic acid-Valine-Aspartic acid DEVD) linked to DOX and to be cleaved into free DOX by caspase-3 expressed with apoptosis. For reactive oxygen species (ROS)-mediated apoptosis, photo-irradiation with methylene blue (MB, photosensitizer) was utilized. The sol-gel transition of the Pluronic NPs containing reactive species, DEVD-S-DOX or MB, was examined by measuring the cloud point and the gel strength in response to temperature change. ROS-mediated apoptosis was observed by measuring the ROS and membrane integrity with induced apoptosis. The in vivo antitumor efficacy of PIATC was measured with a cardiotoxicity assay in tumor-bearing mice.
Asunto(s)
Palabras clave

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Fotoquimioterapia / Profármacos / Doxorrubicina / Fármacos Fotosensibilizantes / Poloxámero / Azul de Metileno / Antineoplásicos Idioma: En Revista: J Control Release Asunto de la revista: FARMACOLOGIA Año: 2017 Tipo del documento: Article

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Fotoquimioterapia / Profármacos / Doxorrubicina / Fármacos Fotosensibilizantes / Poloxámero / Azul de Metileno / Antineoplásicos Idioma: En Revista: J Control Release Asunto de la revista: FARMACOLOGIA Año: 2017 Tipo del documento: Article